Because of the high level of HAGE protein expression in tumours compared with normal tissues, its association with lymphocyte infiltration and the previously reported immunogenic potential of HAGE (Mathieu et al, 2007), this antigen could be proposed as a novel immunotherapeutic target for this sub-group of BC patients with HAGE+ Mathieu et al, 2010).
A new protocol based on this species could be proposed for European homologation tests but its implementation will require the definition of a new standard and take time.
Two possible explanations of this observation could be proposed; first, the agglomeration might appear due to a possible accumulation of proteins and enzymes which were secreted during the biosynthesis, and second, the filtration might prevent the passing of different molecules of protein produced during the process of biosynthesis.
This approach could be proposed only in aggressive acute relapsing MS, where immunosuppression could be associated with specific antiangiogenic therapy.
The group-specific residues reported in this study could be proposed as a group marker of the ERF family for several species.
Furthermore, the data obtained by treatment of sarcoid-derived fibroblasts with imatinib, suggest that this drug could be proposed for a clinical trial leading to therapy of sarcoid in vivo.
These findings confirmed the pivotal role of VSMCs in coronary plaque development and demonstrated a strong site-specific relation between VSMC-secreted CHI3L1 and lesion grade, suggesting that this protein could be proposed as a useful biomarker for diagnosing and staging of atherosclerotic lesions in coronary artery disease.
In this sense, carbon dioxide could be proposed as an oxidant in the oxidative conversions of hydrocarbons.
In this respect, two scenarios could be proposed.
At this stage, two hypotheses could be proposed to explain our results: i) an increased expansion of the alloreactive T cell clones in TLT but of the same specificities as those of the spleen and the draining LN, or ii) a broader activation of T lymphocytes in TLT resulting in the activation of additional T cell clones that were found resting in the draining LN and the spleen.
